NSCLC ASSOCIATED WITH LEPTOMENINGEAL METASTASES

Clinical trials for NSCLC ASSOCIATED WITH LEPTOMENINGEAL METASTASES explained in plain language.

Never miss a new study

Get alerted when new NSCLC ASSOCIATED WITH LEPTOMENINGEAL METASTASES trials appear

Sign up with your email to follow new studies for NSCLC ASSOCIATED WITH LEPTOMENINGEAL METASTASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Spinal fluid injection shows promise for tough lung cancer spread

Disease control Recruiting now

This study tests whether injecting a PD-1 inhibitor (tislelizumab or pembrolizumab) plus pemetrexed directly into the spinal fluid can help people with non-small cell lung cancer that has spread to the lining of the brain (leptomeningeal metastases). The trial will enroll 17 adul…

Matched conditions: NSCLC ASSOCIATED WITH LEPTOMENINGEAL METASTASES

Phase: PHASE2 • Sponsor: West China Hospital • Aim: Disease control

Last updated Jun 27, 2026 12:31 UTC

NSCLC ASSOCIATED WITH LEPTOMENINGEAL METASTASES

Get alerted when new NSCLC ASSOCIATED WITH LEPTOMENINGEAL METASTASES trials appear

Spinal fluid injection shows promise for tough lung cancer spread